Art,
I think what you saying is very important, sorry if I seem to wandering off the track. I do think the purpose of this written piece whether it is written first person, third person or whatever, the goal really is to sell the reader on the idea that "Open Source OpenEMR" is OK and a lower risk than dramatically more expensive proprietary software that may not turn out so well.
I have given quite a few demonstrations and had a lot a lot of outside reviews by insurance companies. The first thing they always say about is OpenEMR "It's easy to use." The second thing they say is "I can't believe it does so much stuff". Finally they say "I can't believe it is free". Then they want to know when I am going to start "selling it" or "patent it." I have a very hard time convincing them that the program really is free, with no catches, and it's not broken. Getting the ONC-ATB certification is pretty good proof that it's not broken.
The poll is on the front page of the SourceForge project page and has been there for a long time. So while I acknowledge that the self reported project acceptance rate of 92% sounds unbelievably high, that is the actual rate. I know that some of the votes were by vendors trying to pump things up on purpose. I also know most of the "I don't like this" votes were obviously Windows users who were trying to double click a Unix tarball and couldn't get the program to install. The last I was able to find they data all of the 4 no votes were of this type. No it's not a scientific survey but it is the only we really have. The no votes went completely away after we started posting the Windows version. The rate of downloads have been falling linearly for the last year from a peak of 5,100 per month to the current rate of around 3,400. I personally feel this happening because we haven't made a Windows installer since Chris Lucena did the 3.2.
How about we call the negative rate "Buyer's remorse." It is also called post purchase dissonance. This effect gets more and more pronounced as the risk, expense and consequences of the purchase go up. In terms of being impactful, I think the hightlighting the "Buyer's remorse" makes a better "hot button" than wimpy acceptance rates.
I will be glad to move the ROI to a different page until we can get a better article.
Art, what order do think we ought to be presenting these paragaphs?
Sam Bowen, MD
